1 active not recruiting. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Active not recruiting 1 |
Follow Neoplasm Malignant: new trials by email Literature Review of Neoplasm Malignant trials Research Report on Neoplasm Malignant
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of XL092 as Single-Agent and Combination Therapy in Subjects With Solid Tumors XL092, Atezolizumab, Avelumab - Neoplasm Malignant, Renal Cell Carcinoma | Phase 1 | Active not recruiting | Exelixis | 325 | 2019-03-20 | 2024-11-19 |
Carcinoma, Renal Cell (1) · Colorectal Neoplasms (1) · Neoplasms (1)
Adenocarcinoma (1) · Carcinoma (1) · Colonic Diseases (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Gastrointestinal Diseases (1) · Gastrointestinal Neoplasms (1) · Intestinal Diseases (1) · Intestinal Neoplasms (1) · Kidney Diseases (1) · Kidney Neoplasms (1) · Male Urogenital Diseases (1) · Neoplasms by Histologic Type (1)
atezolizumab (1) · avelumab (1)
Exelixis (1)
Australia (1) · Belgium (1) · Czechia (1) · France (1) · Germany (1) · Italy (1) · Netherlands (1) · Spain (1) · United Kingdom (1) · United States (1)